2000
Clinical implications of prostate-specific antigen in men and women.
Yu H. Clinical implications of prostate-specific antigen in men and women. Journal Of Gender-Specific Medicine 2000, 3: 45-8, 53. PMID: 11253246.Peer-Reviewed Original ResearchConceptsProstate-specific antigenPresence of PSAClinical implicationsLevels of PSABreast tissueBreast cancer patientsBreast cancer riskSex steroid hormonesValuable tumor markerExcess androgenFavorable prognosisPregnant womenBreast fluidCancer patientsNipple aspiratesProstate cancerClinical studiesCancer riskTumor markersCyst fluidFemale serumSteroid hormonesConcentration of PSAMore studiesWomen
1995
Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumours and their association with other prognostic indicators
Levesque M, Clark G, Yu H, Diamandis E. Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumours and their association with other prognostic indicators. British Journal Of Cancer 1995, 72: 720-727. PMID: 7545416, PMCID: PMC2033897, DOI: 10.1038/bjc.1995.400.Peer-Reviewed Original ResearchConceptsS-phase fractionEpidermal growth factor receptorHER-2/neuProgesterone receptorPrognostic indicatorBreast cancerBreast tumorsProstate-specific antigen expressionIndependent prognostic indicatorP53 proteinProstate-specific antigenAggressive tumor phenotypeWilcoxon rank sum analysisBreast tumor extractsStatus of p53Growth factor receptorPresence of PSARank-sum analysisFavorable prognosisPrognostic factorsBetter prognosisLevels of ERPresence of p53Antigen expressionTumor extracts